期刊文献+

Jug-PLGA-NPs, a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma

原文传递
导出
摘要 Objective: To verrify the anti-tumor efficacy and toxicity between juglone(Jug) and Jug-loaded poly lactic-co-glycolic acid(PLGA) nanoparticles(Jug-PLGA-NPs). Methods: Jug-PLGA-NPs were prepared by ultrasonic emulsification. The anti-tumor activity of Jug(2, 3, 4 μg/mL) and Jug-PLGA-NPs(Jug: 2, 3, 4 μg/mL) in vitro was measured by MTT assay and cell apoptosis analysis. The distribution, anti-tumor effect and biological safety in vivo was evaluated on A375 nude mice. Results: With the advantage of good penetration and targeting properties, Jug-PLGA-NPs significantly inhibited proliferation and migration of melanoma cells both in vitro and in vivo(P<0.05 or P<0.01) with acceptable biocompatibility. Conclusions: Jug can inhibit the growth of melanoma but is highly toxic. With the advantage of sustained release, tumor targeting, anti-tumor activity and acceptable biological safety, Jug-PLGA-NPs provide a new pharmaceutical form for future application of Jug.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2022年第10期909-917,共9页 中国结合医学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China (Nos.81872484 and 82073365) the Social Development Fund of Jiangsu Province,China (No.BE2019605)。
  • 相关文献

参考文献1

二级参考文献13

  • 1李庆,范晓磊.中药抗肿瘤的研究进展[J].中国微生态学杂志,2007,19(3):317-318. 被引量:20
  • 2南京中医药大学.中药大辞典[M].上海:上海科学技术出版社,2009:2182.
  • 3李杨.中药抗肿瘤的优势[J].时珍国医国药,2011,18(10):22-23.
  • 4Reddy JA, agadda VM, Leamon CP. Targeting therapeuticAll and imaging agents to {olate receptor positive tumors [J]. Curr Pharm Biotechnol, 2005,6 (2) : 131-150.
  • 5Chidambararn M, Manavalan R, Kathiresan K. Nanotherapeu- tics to overcome conventional cancer chemo therapy limit ations [J]. J Pharm Pharmaceut Sci, 2011,14(1) : 67-77.
  • 6Zhang L, Sharma S, Hershman JM. Iodide sensitizes genetically modified non-small cell lung cancer cells to ionizing rediation[J].Cancer Gene Therapy, 2006,13 (1) .. 74-81.
  • 7Zhang HZ, Li XM, Gao EP, et a l. Pre Parationoffolate-modified Pullulan aeetate nanoparticles for tumor-targeted drug delivery[J]. Drug Delivery, 2010,17 (1) : 48-57.
  • 8Abra RM,Bankert RB, Chen F,etal. The next generation of li- posome delivery systems :recent experience with tumor-targe-ted, sterically-stabilized immunoliposomes and active-loading gradients[J]. J Liposome Res,2002,12:1-3.
  • 9Low PS, Kularame SA. Folate-targeted therapeutic and ima- ging agents for gence TE[J]. Curr Opin Chem Biol,2009,13(3) : 256-262.
  • 10Zheng Y, Song XR, Darby M, et al. Preparation and characterization of folate-poly (ethylene glycol) for Intra- cell-ular transport of protein through folate receptor- mediated en- docytosis[J].J Bioteehnol,2010,145(1 ) :47-53.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部